A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
NCT ID: NCT07335354
Last Updated: 2026-01-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
131 participants
INTERVENTIONAL
2026-01-05
2029-01-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Decision Aid for Women With Early Stage Breast Cancer
NCT00201929
Implementation of a Web-based Decision Aid for Breast Cancer Surgery
NCT03304002
Factors Associated With Breast Cancer Risks and Outcomes
NCT07294703
A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older
NCT02823262
Registry of Mastectomy for Breast Cancer Risk Reduction
NCT00555503
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Focus Group Participants
Participants will receive usual care
No interventions assigned to this group
RECONJOINT/RCT Participants (Patients)
Participants in the RECONJOINT intervention arm will receive the decision aid in addition to enhanced usual care
RECONJOINT
RECONJOINT is a Breast Reconstruction Decision Aid
RCT Participants (Physicians)
Participating surgeons will be randomized to Enhanced Usual Care or Intervention with a 1:1 ratio
RECONJOINT
RECONJOINT is a Breast Reconstruction Decision Aid
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RECONJOINT
RECONJOINT is a Breast Reconstruction Decision Aid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
* ≥18 years old
* Considering post-mastectomy breast reconstruction
RCT Participants (Patients)
* A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
* ≥18 years old
* Considering post-mastectomy breast reconstruction
* Have an appointment scheduled for consultation with a plastic surgery provider
RCT Participants (Physicians)
* Provides breast reconstruction care ≥ 50% of the time. This is defined as over half of the surgeon's cases in the preceding calendar year being related to breast reconstruction surgery.
Exclusion Criteria
* Not considering post-mastectomy breast reconstruction
* Non-English proficiency
RCT Participants (Patients)
* Not considering postmastectomy breast reconstruction
* Recurrent or metastatic breast cancer
* Male sex
* Non-English proficiency
RCT Participants (Physicians)
* Does not provide breast reconstruction care at least 50% of the time
* Non-English proficiency
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Evan Matros, MD
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth
Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen
Montvale, New Jersey, United States
Memorial Sloan Kettering Commack
Commack, New York, United States
Memorial Sloan Kettering Westchester
Harrison, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Memorial Sloan Kettering Nassau
Rockville Centre, New York, United States
Duke Cancer Institute (Data collection only)
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Evan Matros, MD
Role: primary
Evan Matros, MD
Role: primary
Evan Matros, MD
Role: primary
Evan Matros, MD
Role: primary
Evan Matros, MD
Role: primary
Evan Matros, MD
Role: primary
Evan Matros, MD
Role: primary
Brett Phillips
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
25-079
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.